Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Indication for Anticoagulation”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT02239887
What this trial is testing

Coherex WAVECREST I Left Atrial Appendage Occlusion Study

Who this might be right for
Non-valvular Paroxysmal, Persistent, or Permanent Atrial FibrillationLAA Anatomy Amenable to Treatment by Percutaneous TechniqueAnticoagulation Indication for Potential Thrombus Formation in the Left Atrium
Coherex Medical 155
Large-scale testing (Phase 3)Looking for participantsNCT04284839
What this trial is testing

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Who this might be right for
Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute 3,500
Large-scale testing (Phase 3)Ended earlyNCT04217447
What this trial is testing

Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University Hospital, Brest 874
Post-approval studies (Phase 4)Not Yet RecruitingNCT06901466
What this trial is testing

STrategies for AntithRombotic Treatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

Who this might be right for
Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital 880
Post-approval studies (Phase 4)WithdrawnNCT02723981
What this trial is testing

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials

Who this might be right for
Stable AnginaUnstable AnginaSTEMI+2 more
IHF GmbH - Institut für Herzinfarktforschung
Large-scale testing (Phase 3)Ended earlyNCT03302494
What this trial is testing

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Who this might be right for
Stroke
Coherex Medical 248
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Large-scale testing (Phase 3)UnknownNCT00691470
What this trial is testing

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Who this might be right for
Atrial FibrillationAtrial FlutterVenous Thromboembolic Disease+2 more
ARYx Therapeutics 600